Go Pro

Danaher (DHR) Stock Price, News & Analysis

Danaher logo
$207.46 -3.57 (-1.69%)
As of 09/4/2026 03:58 PM Eastern

About Danaher Stock (NYSE:DHR)

Advanced

Key Stats

Today's Range
$205.23
$208.70
50-Day Range
$179.01
$219.42
52-Week Range
$160.93
$242.80
Volume
2.90 million shs
Average Volume
3.14 million shs
Market Capitalization
$145.84 billion
P/E Ratio
36.85
Dividend Yield
0.77%
Price Target
$228.91
Consensus Rating
Moderate Buy

Company Overview

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs. Danaher’s operating companies deliver equipment and consumables used in sample preparation, molecular and cellular analysis, clinical diagnostics, water quality testing and other applied testing workflows, often combining hardware with software and service offerings to provide end-to-end solutions for customers.

Founded in 1969, Danaher has grown through organic development and acquisitions to build a diversified group of technology-oriented businesses. The company is headquartered in Washington, D.C., and serves customers worldwide across North America, Europe, Asia and other global markets. Danaher is also known for its emphasis on continuous improvement and operational excellence through the Danaher Business System, and it is governed by a board of directors and an executive leadership team. The company is publicly traded on the New York Stock Exchange under the ticker DHR.

AI Generated. May Contain Errors.

Danaher Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
92nd Percentile Overall Score

DHR MarketRank™: 

Danaher scored higher than 92% of companies evaluated by MarketBeat, and ranked 42nd out of 912 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Danaher has received a consensus rating of Moderate Buy. The company's average rating score is 2.84, and is based on 1 strong buy rating, 19 buy ratings, 5 hold ratings, and no sell ratings.

  • Upside Potential

    Danaher has a consensus price target of $228.91, representing about 10.3% upside from its current price of $207.46.

  • Amount of Analyst Coverage

    Danaher has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Danaher's stock forecast and price target.
  • Earnings Growth

    Earnings for Danaher are expected to grow by 8.56% in the coming year, from $8.53 to $9.26 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Danaher is 36.85, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.27.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Danaher is 36.85, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.43.

  • Price to Earnings Growth Ratio

    Danaher has a PEG Ratio of 2.63. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Danaher has a P/B Ratio of 2.77. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Danaher's valuation and earnings.
  • Percentage of Shares Shorted

    1.40% of the float of Danaher has been sold short.
  • Short Interest Ratio / Days to Cover

    Danaher has a short interest ratio ("days to cover") of 2.65, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Danaher has recently decreased by 27.27%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Danaher has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Danaher has only been increasing its dividend for 2 years.

  • Dividend Coverage

    The dividend payout ratio of Danaher is 28.42%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Danaher will have a dividend payout ratio of 17.28% next year. This indicates that Danaher will be able to sustain or increase its dividend.

  • Read more about Danaher's dividend.
  • News Sentiment

    Danaher has a news sentiment score of 1.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 29 news articles for Danaher this week, compared to 9 articles on an average week.
  • Search Interest

    Only 12 people have searched for DHR on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • MarketBeat Follows

    25 people have added Danaher to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Danaher insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.80% of the stock of Danaher is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    79.05% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Danaher's insider trading history.
Receive DHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DHR Stock News Headlines

Danaher (DHR) Seen Deftly Navigating AI Integration
Danaher (DHR) Seen Deftly Navigating AI Integration
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
Is Danaher Stock Underperforming the Nasdaq?
Is Danaher Stock Underperforming the Nasdaq?
Why Danaher (DHR) Remains a Healthcare Compounder to Watch
See More Headlines

DHR Stock Analysis - Frequently Asked Questions

Danaher's stock was trading at $228.99 at the beginning of 2026. Since then, DHR shares have decreased by 9.4% and is now trading at $207.46.

Danaher Corporation (NYSE:DHR) released its earnings results on Monday, July, 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. Danaher's revenue was up 5.5% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Danaher: Aldevron, Precision NanoSystems, Aquatic Informatics, Cytiva, GE Biopharma, Integrated DNA Technologies, IDBS Group, and others.

Top institutional investors of Danaher include California State Teachers Retirement System (26.26%), BlackRock Inc. (7.84%), Wellington Management Group LLP (2.32%) and BlackRock Inc. (1.86%). Insiders that own company stock include Steven M Rales, Steven M Rales, Alan G Spoon, Rainer Blair, Joakim Weidemanis, Linda Filler, Daniel Raskas, Matthew Mcgrew, Teri List, Christopher Paul Riley, Brian W Ellis, Walter G Lohr, Gregory M Milosevich and Georgeann Couchara.
View institutional ownership trends
.

Shares of DHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Danaher investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), UnitedHealth Group (UNH), BlackRock (BLK), JPMorgan Chase & Co. (JPM) and Advanced Micro Devices (AMD).

Company Calendar

Record date for 7/31 Dividend
6/26/2026
Ex-Dividend for 7/31 Dividend
6/26/2026
Last Earnings
7/20/2026
Dividend Payable
7/31/2026
Today
9/04/2026
Next Earnings (Estimated)
10/20/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:DHR
CIK
313616
Employees
60,000
Year Founded
1984

Price Target and Rating

High Price Target
$270.00
Low Price Target
$195.00
Potential Upside/Downside
+10.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.84
Research Coverage
25 Analysts

Profitability

EPS (Trailing Twelve Months)
$5.63
Trailing P/E Ratio
36.85
Forward P/E Ratio
24.32
P/E Growth
2.63
Net Income
$3.61 billion
Net Margins
15.95%
Pretax Margin
18.97%
Return on Equity
11.04%
Return on Assets
6.81%

Debt

Debt-to-Equity Ratio
0.48
Current Ratio
1.65
Quick Ratio
1.25

Sales & Book Value

Annual Sales
$25.11 billion
Price / Sales
5.81
Cash Flow
$11.18 per share
Price / Cash Flow
18.56
Book Value
$74.81 per share
Price / Book
2.77

Miscellaneous

Outstanding Shares
702,986,000
Free Float
627,064,000
Market Cap
$145.84 billion
Optionable
Optionable
Beta
0.78

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NYSE:DHR) was last updated on 9/5/2026 by MarketBeat.com Staff.
From Our Partners